Procter & Gamble Health Limited

Symbol: PGHL.NS

NSE

4777.1

INR

Market price today

  • 34.9865

    P/E Ratio

  • 1.4743

    PEG Ratio

  • 79.30B

    MRK Cap

  • 0.05%

    DIV Yield

Procter & Gamble Health Limited (PGHL-NS) Financial Statements

On the chart you can see the default numbers in dynamics for Procter & Gamble Health Limited (PGHL.NS). Companys revenue shows the average of 7910.147 M which is 0.028 % gowth. The average gross profit for the whole period is 4661.51 M which is 0.047 %. The average gross profit ratio is 0.583 %. The net income growth for the company last year performance is 0.192 % which equals 0.389 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Procter & Gamble Health Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.232. In the realm of current assets, PGHL.NS clocks in at 7961 in the reporting currency. A significant portion of these assets, precisely 4527.8, is held in cash and short-term investments. This segment shows a change of 0.418% when juxtaposed with last year's data. The debt profile of the company shows a total long-term debt of 88.8 in the reporting currency. This figure signifies a year_over_year change of 3.240%. Shareholder value, as depicted by the total shareholder equity, is valued at 7508.9 in the reporting currency. The year over year change in this aspect is 0.218%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 1172.4, with an inventory valuation of 1349.4, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 9.4.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

17298.54527.831944640.5
6390.9
12429
3477.1
3070.5
2295.1
1866.6
2107.1
2152.5
1132.8
1427.7
3246.4
1847.7
1169.1

balance-sheet.row.short-term-investments

17336.9177.3125.9108.4
0
-851.4
699.7
277.8
422.8
238.7
242.9
236.4
0
0
0
0
0

balance-sheet.row.net-receivables

2543.91172.41043.6717.2
999.4
929.2
1602.4
1503.9
1622.1
1288.4
1085.5
1056.4
0
0
0
0
0

balance-sheet.row.inventory

2639.91349.41152.11183.7
1360
1133.5
1577.4
1658.9
1668.6
1773.2
1518.2
1309.6
1130.9
611.2
584.9
729.8
362.9

balance-sheet.row.other-current-assets

1706.3911.4746.7730
811.6
851.3
866.4
176.2
138.3
58.2
69.9
66.4
1779.9
1512.1
971.8
876.4
618.6

balance-sheet.row.total-current-assets

24188.679616136.47271.4
9561.9
15343
7523.3
6409.5
5724.1
4986.4
4780.7
4584.9
4043.6
3551
4803.1
3453.9
2150.6

balance-sheet.row.property-plant-equipment-net

3414.11732.71496.21401.3
1194.2
1176.7
1265
1404.7
1385.9
1371.5
937.9
767.7
725.2
512.4
640.3
622.1
405

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

9.49.40.41.2
2.1
4.3
7.9
0
1.4
1.9
2.7
1.3
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

16.49.40.41.2
2.1
4.3
7.9
1.7
1.4
1.9
2.7
1.3
0
0
0
0
0

balance-sheet.row.long-term-investments

28.7-126.4-38.3-26.6
33.7
890.4
-613.6
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

522.4253.2196.5199.1
157.9
180.3
308
173.4
56.8
21.7
0
0
0
34.6
0
0
0

balance-sheet.row.other-non-current-assets

2127.3118211461015.2
814
-0.1
1421.6
839
671.5
700.7
764.8
588.8
227.4
201.8
238.2
1529.3
2339.7

balance-sheet.row.total-non-current-assets

6108.93050.92800.82590.2
2201.9
2251.6
2388.9
2418.8
2115.6
2095.8
1705.4
1357.8
952.6
748.8
878.5
2151.4
2744.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

21782.411011.98937.29861.6
11763.8
17594.6
9912.2
8828.3
7839.7
7082.2
6486.1
5942.7
4996.2
4299.8
5681.6
5605.3
4895.3

balance-sheet.row.account-payables

4086.52370.41760.11287.6
1239.6
914.2
832.8
751.1
655.5
437.7
368.1
408.6
0
0
0
0
0

balance-sheet.row.short-term-debt

58.931.228.347.5
79
65.3
67.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

10261.386.842.5
45.1
200.9
206.1
0
67.4
51.1
50.9
35.3
0
0
0
0
0

balance-sheet.row.long-term-debt-total

169.188.8028.6
0
0
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

609.789.2564.382.4
943.8
980.7
1352.7
1333
1003.1
914.4
755.1
562.1
887
835.6
987.5
1067.6
618.3

balance-sheet.row.total-non-current-liabilities

870.7464414434.8
427
233.3
327
289.6
265.6
187.1
132.6
135.4
8.4
0
21.2
23.8
48

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

200.312028.376.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

6214.735032772.32824.5
2700.4
2193.5
2579.6
2373.7
1924.2
1539.2
1255.8
1106.1
895.4
835.6
1008.7
1091.4
666.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

332166166166
166
166
166
166
166
166
166
166
166
166
166
168.6
168.6

balance-sheet.row.retained-earnings

3709.13709.12370.73277
5322.6
11679.7
3611.2
2733.2
2270
1937.8
1668.3
1330.5
0
0
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

3519.93519.93514.33482.8
3463.5
-853.6
-759.6
-1548.5
-1263.1
-1089
-991.3
0
-964.4
-1043.3
-854.7
-801.3
-787.8

balance-sheet.row.other-total-stockholders-equity

8006.7113.9113.9111.3
111.3
4409
4315
5103.9
4742.6
4528.2
4387.3
3340.1
4899.2
4341.5
5361.6
5146.6
4848.2

balance-sheet.row.total-stockholders-equity

30421.27508.96164.97037.1
9063.4
15401.1
7332.6
6454.6
5915.5
5543
5230.3
4836.6
4100.8
3464.2
4672.9
4513.9
4229

balance-sheet.row.total-liabilities-and-stockholders-equity

21782.411011.98937.29861.6
11763.8
17594.6
9912.2
8828.3
7839.7
7082.2
6486.1
5942.7
4996.2
4299.8
5681.6
5605.3
4895.3

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

30421.27508.96164.97037.1
9063.4
15401.1
7332.6
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

21782.4---
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

17236.250.987.681.8
33.7
39
86.1
277.8
422.8
238.7
242.9
236.4
227.4
201.8
238.2
1529.3
2339.7

balance-sheet.row.total-debt

22812028.376.1
0
65.3
67.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

137-4230.5-3165.7-4564.4
-6390.9
-12363.7
-2710.3
-2792.7
-1872.3
-1627.9
-1864.2
-1916.1
-1132.8
-1427.7
-3246.4
-1847.7
-1169.1

Cash Flow Statement

The financial landscape of Procter & Gamble Health Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 0.471. The company recently extended its share capital by issuing 0, marking a difference of 0.000 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 639.2 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -215000000.000 in the reporting currency. This is a shift of -0.158 from the previous year. In the same period, the company recorded 281, 162.4, and -46.8, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -937.9 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as -46.8, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

2313.831422533.72332.8
1693.9
11375.7
1521.9
1102.2
833.3
665.6
882.5
1167.9
955.9
957.1
964.5
917.4
998.6

cash-flows.row.depreciation-and-amortization

0281270.8300.4
192.9
249.9
264
275.5
234.2
126.8
100.7
89
79.5
71
75.1
57.3
65.9

cash-flows.row.deferred-income-tax

0-612.20-541.9
-550.2
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

05.634.119.3
19.7
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-300.3-473525.5
-57.3
-502.6
-478.1
311.4
156.4
-485.3
-509.4
-144
-722.4
54.9
-48.8
-295.7
-12.7

cash-flows.row.account-receivables

0-329.2-251.5347
-292
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-323.9-20.2152.6
-207.5
-280
41.3
-7.9
93.6
-255.2
-234.3
-206.1
-531.4
-25
133.8
-374.5
-1

cash-flows.row.account-payables

0639.2-6518.1
354.7
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-286.4-136.37.8
87.5
-222.6
-519.4
319.3
62.8
-230.1
-275.1
62.1
-191
79.9
-182.6
78.8
-11.7

cash-flows.row.other-non-cash-items

-2313.8-156.1-670.4-163.5
1660.4
-12426.8
-771.2
-618.7
-387.3
-257.6
-469.3
-570.3
-568.4
-423.3
-573.4
-640.1
-670.7

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-424.8-379.2-525.8
-232.7
-267.2
-303
-316.5
-451.9
-403.8
-334.1
-136.1
-150.6
-87.9
-95.5
-293.4
-71.2

cash-flows.row.acquisitions-net

047.43.712.1
3
10520
200.7
158.5
370.2
-117.3
421.8
1472.1
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
-1056.9
-3774.6
-9310.6
-10110.5
-9113.3
-8553
-8392.5
-6760.8
-12243.7
-11261.1
-16427.2
-17033.3

cash-flows.row.sales-maturities-of-investments

0000
1238.1
3197.1
3204
8718
9719.4
9428.7
8541.1
7310.9
7335.7
14304.2
11135.8
16561.4
17088.8

cash-flows.row.other-investing-activites

0162.4120.1191
32.4
304.2
196.6
0.9
-207.5
311.4
-5.4
-1072.6
136.9
-208.6
236.8
317.1
226.5

cash-flows.row.net-cash-used-for-investing-activites

0-215-255.4-322.7
1040.8
12697.2
-476.3
-749.7
-680.3
105.7
70.4
-818.2
561.2
1764
16
157.9
210.8

cash-flows.row.debt-repayment

0-46.8-47.8-48.5
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
-0.2
-1.7
-107.4
0
0

cash-flows.row.dividends-paid

0-937.9-2838.5-3817.8
-8834.1
-249
-182.6
-124.5
-99.3
-142.2
-41.5
0
0
-1899.4
-294.6
-168.2
-504

cash-flows.row.other-financing-activites

0-46.8-47.8-48.5
-5622.8
-51.5
-37.2
-25.3
-19.9
-24
-6.7
0
0
-318.3
-50.1
-28.7
-71

cash-flows.row.net-cash-used-provided-by-financing-activities

0-984.7-2886.3-3866.3
-8834.1
-300.5
-219.8
-149.8
-119.2
-166.2
-48.2
0
-0.2
-2219.4
-452.1
-196.9
-575

cash-flows.row.effect-of-forex-changes-on-cash

0-0.100
-841.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

01160.2-1446.5-1716.4
-4805.2
11092.9
-159.5
170.9
37.1
-11
26.7
-275.6
305.6
204.3
-18.7
-0.1
16.9

cash-flows.row.cash-at-end-of-period

04354.231944640.5
6390.9
11196.1
103.2
262.7
91.8
54.7
65.7
39
523.3
217.7
13.4
32.1
32.2

cash-flows.row.cash-at-beginning-of-period

031944640.56356.9
11196.1
103.2
262.7
91.8
54.7
65.7
39
314.6
217.7
13.4
32.1
32.2
15.3

cash-flows.row.operating-cash-flow

023601695.22472.6
2959.3
-1303.8
536.6
1070.4
836.6
49.5
4.5
542.6
-255.4
659.7
417.4
38.9
381.1

cash-flows.row.capital-expenditure

0-424.8-379.2-525.8
-232.7
-267.2
-303
-316.5
-451.9
-403.8
-334.1
-136.1
-150.6
-87.9
-95.5
-293.4
-71.2

cash-flows.row.free-cash-flow

01935.213161946.8
2726.6
-1571
233.6
753.9
384.7
-354.3
-329.6
406.5
-406
571.8
321.9
-254.5
309.9

Income Statement Row

Procter & Gamble Health Limited's revenue saw a change of 0.126% compared with the previous period. The gross profit of PGHL.NS is reported to be 8677.8. The company's operating expenses are 5719.3, showing a change of 33.417% from the last year. The expenses for depreciation and amortization are 281, which is a 0.038% change from the last accounting period. Operating expenses are reported to be 5719.3, which shows a 33.417% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.207% year-over-year growth. The operating income is 3142.4, which shows a 0.207% change when compared to the previous year. The change in the net income is 0.192%. The net income for the last year was 2294.7.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

1237012296.210920.49907.9
9033.8
8489.9
11039.6
9925.6
9375.6
8629
7939.6
6564.2
5575.7
5090.8
4731.1
3894.6
3148.3

income-statement-row.row.cost-of-revenue

4358.13618.43671.13392.7
5016.3
2713.4
4454.9
4166.3
4522.7
4164.8
3805.5
3019.9
2427.8
2078.7
2060.9
1599.9
1264.9

income-statement-row.row.gross-profit

8011.98677.87249.36515.2
4017.6
5776.5
6584.7
5759.3
4852.9
4464.2
4134.1
3544.3
3147.9
3012.1
2670.2
2294.7
1883.4

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

1659.1183.92893.62938.1
-73.9
-489.5
-498.3
-307.8
5.5
5.6
5.1
-205.3
2191.8
2054.3
1705.4
1377.2
884.7

income-statement-row.row.operating-expenses

5139.25719.34286.84316
2049.1
3998.2
4725.7
4515.4
4212.8
3998.6
3454
2362
2191.8
2054.3
1705.4
1377.2
884.7

income-statement-row.row.cost-and-expenses

9497.39337.77957.97708.7
7065.4
6711.6
9180.6
8681.7
8735.5
8163.4
7259.5
5381.9
4619.6
4133
3766.3
2977.1
2149.6

income-statement-row.row.interest-income

0098.8150.6
572.5
171.9
178.9
177.2
154.7
164.8
181.4
172.4
0
0
0
0
0

income-statement-row.row.interest-expense

7.57.74.28
0
-7237.3
402.3
200.7
-180.3
-196.7
-190.3
19.1
0.2
0.7
0.3
0.1
0.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

66.8-0.4-69.4-17
397.3
-132.6
-402.3
-200.7
180.3
196.7
190.3
-19.1
-0.2
-143.5
-0.3
-0.1
-0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

1659.1183.92893.62938.1
-73.9
-489.5
-498.3
-307.8
5.5
5.6
5.1
-205.3
2191.8
2054.3
1705.4
1377.2
884.7

income-statement-row.row.total-operating-expenses

66.8-0.4-69.4-17
397.3
-132.6
-402.3
-200.7
180.3
196.7
190.3
-19.1
-0.2
-143.5
-0.3
-0.1
-0.1

income-statement-row.row.interest-expense

7.57.74.28
0
-7237.3
402.3
200.7
-180.3
-196.7
-190.3
19.1
0.2
0.7
0.3
0.1
0.1

income-statement-row.row.depreciation-and-amortization

257.9281270.8300.4
192.9
249.9
264
275.5
234.2
126.8
100.7
89
79.5
71
75.1
57.3
65.9

income-statement-row.row.ebitda-caps

3295.4---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

3037.53142.42603.12349.8
1968.4
1712.4
1924.2
1302.9
653
468.9
692.2
1187
956.1
1100.6
964.8
917.5
998.7

income-statement-row.row.income-before-tax

3104.331422533.72332.8
2365.7
1579.8
1521.9
1102.2
833.3
665.6
882.5
1167.9
955.9
957.1
964.5
917.4
998.6

income-statement-row.row.income-tax-expense

837.8847.3608.5564.8
671.8
562.5
582.8
343.3
297.7
233.4
323.7
383.9
319.1
325.3
309.7
287.3
310.4

income-statement-row.row.net-income

2266.52294.71925.21768
1693.9
8387.2
939.1
758.9
535.6
432.2
558.8
784
636.8
631.8
654.8
630.1
688.2

Frequently Asked Question

What is Procter & Gamble Health Limited (PGHL.NS) total assets?

Procter & Gamble Health Limited (PGHL.NS) total assets is 11011900000.000.

What is enterprise annual revenue?

The annual revenue is 6149000000.000.

What is firm profit margin?

Firm profit margin is 0.648.

What is company free cash flow?

The free cash flow is 0.000.

What is enterprise net profit margin?

The net profit margin is 0.183.

What is firm total revenue?

The total revenue is 0.246.

What is Procter & Gamble Health Limited (PGHL.NS) net profit (net income)?

The net profit (net income) is 2294700000.000.

What is firm total debt?

The total debt is 120000000.000.

What is operating expences number?

The operating expences are 5719300000.000.

What is company cash figure?

Enretprise cash is 4255600000.000.